0012 GMT - Mondelez's CEO said the broader snacking category is not diminishing due to consumers' focus on health and wellness. There hasn't been any noticeable decrease in snacking consumption due to GLP-1 medications, either, Dirk Van de Put said. "Since COVID, the indulgence part of snacking is growing just as fast as the healthy part," he said. The snack giant reported a profit of $1.75 billion for the fourth quarter, compared with $950 million a year earlier. (roshan.fernandez@wsj.com)
(END) Dow Jones Newswires
February 04, 2025 19:13 ET (00:13 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。